Skip to main content

Table 1 Participant demographic characteristics (n = 43)

From: Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5

Characteristic

Percentage or mean (standard deviation)

Sex (%)

 Female

48.8% (n = 21)

Race (%)

 Non-Hispanic White

37.2% (n = 16)

 Non-Hispanic Black

60.5% (n = 26)

 Asian

2.3% (n = 1)

Age (years)

61.9 ± 9.0

WC (cm)

109.7 ± 21.6

WC ≥ 94 cm (men) or 80 cm (women) (%)

81.5% (n = 35)

BMI (kg/m2)

34.1 ± 8.3

Antihypertensive medication use (%)

100% (n = 43)

HbA1c (%)

8.3 ± 1.6

LDL cholesterol (mg/dL)

89 ± 40

Cardiovascular procedure (%)*

 Catheterization

11.6% (n = 5)

 Percutaneous coronary intervention (PCI)

4.7% (n = 2)

 Coronary artery bypass surgery (CABG)

7.0% (n = 3)

 PCI and CABG

4.7% (n = 2)

  1. *Collectively this represents the total number of individuals included in the FKBP5 analysis model with a history of cardiovascular procedures (n = 12)